USNA
USANA Health Sciences, Inc.NYSEConsumer Defensive$16.90-1.86%ClosedMarket Cap: $311.9M
As of 2026-04-06
Valuation
P/E (TTM)
28.99
PEG
—
P/B
0.58
P/S
0.34
EV/EBITDA
1.76
DCF Value
$103.32
FCF Yield
2.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
78.3%
Operating Margin
5.5%
Net Margin
1.2%
ROE
2.0%
ROA
2.3%
ROIC
2.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $226.2M | 88.8% | $17.2M | $-1.8M | $-0.10 | — |
| FY 2025 | $925.3M | 78.3% | $50.9M | $10.8M | $0.58 | — |
| Q3 2025 | $213.7M | 73.4% | $1.2M | $-6.5M | $-0.36 | — |
| Q2 2025 | $235.8M | 75.4% | $16.7M | $9.7M | $0.52 | — |
| Q1 2025 | $249.5M | 75.6% | $15.7M | $9.4M | $0.49 | — |
| Q4 2024 | $213.6M | 80.1% | $8.2M | $4.5M | $0.23 | — |
| FY 2024 | $854.5M | 79.4% | $66.3M | $42.0M | $2.19 | — |
| Q3 2024 | $200.2M | 78.6% | $15.6M | $10.6M | $0.56 | — |
| Q2 2024 | $212.9M | 79.3% | $17.8M | $10.4M | $0.54 | — |
| Q1 2024 | $227.8M | 79.7% | $24.7M | $16.5M | $0.86 | — |
| Q4 2023 | $221.1M | 79.5% | $24.2M | $16.8M | $0.87 | — |
| FY 2023 | $921.0M | 79.4% | $93.1M | $63.8M | $3.30 | — |